Quality indicators for the management of endometrial, cervical and ovarian cancer

被引:18
|
作者
Bonte, Anne-Sophie [1 ,2 ]
Luyckx, Annemie [1 ,2 ]
Wyckmans, Leen [1 ,2 ]
Trinh, Xuan Bich [1 ,2 ]
van Dam, Peter A. [1 ,2 ]
机构
[1] Antwerp Univ Hosp, MOCA, B-2650 Edegem, Belgium
[2] Univ Antwerp, Ctr Oncol Res CORE, B-2610 Antwerp, Belgium
来源
EJSO | 2019年 / 45卷 / 04期
关键词
Quality indicators; Guidelines; Endometrial cancer; Cervical cancer; Ovarian cancer; OF-CARE; RADICAL HYSTERECTOMY; LYMPH-NODES; SURVIVAL; THERAPY; BRACHYTHERAPY; SURGERY; IMPACT; ASSOCIATION; GUIDELINES;
D O I
10.1016/j.ejso.2018.10.051
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Objective: Measuring quality indicators improves the quality of care. The aim of this review is to identify a set of quality indicators (QIs) that can be used to measure the standard of treatment for patients with endometrial, cervical and ovarian cancer. Methods: A systematic literature search was performed in the Pubmed and Google Scholar database. Articles related to the field of interest, which covered QIs for the management of endometrial, cervical and ovarian cancer, were included if they were written in English and available in full text. Articles related to prevention, screening, diagnosis, quality of life and patient satisfaction were excluded. Results: A total of 57 suitable articles was found: 13 for endometrial cancer, 17 for cervical cancer and 27 for ovarian cancer. An overview of the selected QIs was made and classified by type of indicator. Relevant QIs related to the structural organisation of health care are: referral to high volume specialists in high volume hospitals, treatment by specialized gynecological oncologists and discussion of treatment plan by a multi-disciplinary team according to current guidelines. Important process measures are: a patient report of high quality, an adequate pretreatment staging and an adherence to treatment guidelines. The ultimate goal is to reduce treatment related morbidity and increase the survival rate, which can be measured as outcome indicators. Conclusion: The proposed set of QIs should be validated and can be implemented into quality assurance programmes to improve the quality of care and the outcome of patients with a gynecological cancer. (C) 2018 Elsevier Ltd, BASO similar to The Association for Cancer Surgery, and the European Society of Surgical Oncology. All rights reserved.
引用
收藏
页码:528 / 537
页数:10
相关论文
共 50 条
  • [31] Quality of life and mental health in cervical and endometrial cancer survivors
    Bradley, S
    Rose, S
    Lutgendorf, S
    Costanzo, E
    Anderson, B
    [J]. GYNECOLOGIC ONCOLOGY, 2006, 100 (03) : 479 - 486
  • [32] HE4 as a biomarker for ovarian and endometrial cancer management
    Li, Jinping
    Dowdy, Sean
    Tipton, Tracy
    Podratz, Karl
    Lu, Wei-Guo
    Xie, Xing
    Jiang, Shi-Wen
    [J]. EXPERT REVIEW OF MOLECULAR DIAGNOSTICS, 2009, 9 (06) : 555 - 566
  • [33] FDG-PET for management of cervical and ovarian cancer
    Havrilesky, LJ
    Kulasingam, SL
    Matchar, DB
    Myers, ER
    [J]. GYNECOLOGIC ONCOLOGY, 2005, 97 (01) : 183 - 191
  • [34] ESGO/ESTRO quality indicators for radiation therapy of cervical cancer
    Chargari, Cyrus
    Tanderup, Kari
    Planchamp, Francois
    Chiva, Luis
    Humphrey, Pauline
    Sturdza, Alina
    Tan, Li T.
    van der Steen-banasik, Elzbieta
    Zapardiel, Ignacio
    Nout, Remi A.
    Fotopoulou, Christina
    [J]. INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, 2023, 33 (06) : 862 - 875
  • [35] CLINICOPATHOLOGICAL FEATURES OF ENDOMETRIAL CANCER WITH OVARIAN METASTASIS AND SYNCHRONOUS ENDOMETRIAL AND OVARIAN CANCER
    Kaneda, M.
    Nagao, S.
    Suzuki, K.
    Shibutani, T.
    Yamamoto, K.
    Jimi, T.
    Yano, H.
    Kitai, M.
    Shiozaki, T.
    Matsuoka, K.
    Sudo, T.
    Yamaguchi, S.
    [J]. INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, 2018, 28 : 1103 - 1103
  • [36] The Role of Selenium and Manganese in the Formation, Diagnosis and Treatment of Cervical, Endometrial and Ovarian Cancer
    Golara, Anna
    Kozlowski, Mateusz
    Guzik, Pawel
    Kwiatkowski, Sebastian
    Cymbaluk-Ploska, Aneta
    [J]. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2023, 24 (13)
  • [37] Incidence of cervical, endometrial, and ovarian cancer in Korea during 1999-2015
    Lim, Myong Cheol
    Won, Young-Joo
    Ko, Mun Jung
    Kim, Miseon
    Shim, Seung-Hyuk
    Suh, Dong Hoon
    Kim, Jae-Weon
    [J]. JOURNAL OF GYNECOLOGIC ONCOLOGY, 2019, 30 (01)
  • [38] Adverse impact of a history of violence for women with breast, cervical, endometrial, or ovarian cancer
    Modesitt, Susan C.
    Gambrell, Alisa C.
    Cottrill, Hope M.
    Hays, Lon R.
    Walker, Robert
    Shelton, Brent J.
    Jordan, Carol E.
    Ferguson, James E., II
    [J]. OBSTETRICS AND GYNECOLOGY, 2006, 107 (06): : 1330 - 1336
  • [39] The socio-economic burden of endometrial, ovarian, cervical, and vaginal cancer survivorship
    Michaeli, J. C.
    Michaeli, D. T.
    Boch, T.
    Albers, S.
    Michaeli, T.
    [J]. ANNALS OF ONCOLOGY, 2022, 33 (07) : S823 - S824
  • [40] FHIT gene expression in human ovarian, endometrial, and cervical cancer cell lines
    Hendricks, DT
    Taylor, R
    Reed, M
    Birrer, MJ
    [J]. CANCER RESEARCH, 1997, 57 (11) : 2112 - 2115